How much does it cost to reimburse yourself for Crizotinib?

The original drug Crizotinib (Crizotinib) has been launched in China and is included in the scope of medical insurance, but it is only reimbursable for patients who meet the indications, such as patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer or R For patients with OS1-positive advanced non-small cell lung cancer (NSCLC) , the price of each box sold in China may be around RMB 15,000. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. Please consult the local medical insurance bureau or hospital to learn about their reimbursement regulations.

The labeling for crizotinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive by an FDA-approved test, and for the treatment of patients with metastatic non-small cell lung cancer who are ALK-positive. Pediatric patients 1 year and older and young adults with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL); and adult and pediatric patients 1 year and older with ALK-positive unresectable, relapsed, or refractory inflammatory myofibroblastic tumor (IMT). Currently safety and efficacy in older adults with relapsed or refractory systemicALK-positive ALCL have not been established.

The Turkish original version of crizotinib currently sold overseas may cost more than RMB 10,000 per box (the price may fluctuate due to the exchange rate), which is expensive. There are also cheaper generic crizotinib drugs available overseas. The ingredients are basically similar to those of the original drugs sold domestically and abroad. For example, the price of 250mg*60 tablets produced by a Bangladesh pharmaceutical factory may be more than 2,000 yuan per box (the price may fluctuate due to exchange rates).